Related Experiment Videos
A new HLA-A1 mutation: a novel, null variant allele
John Bernard Henry1, Charlene A Hubbell, Mary C Davis
1Department of Pathology, SUNY Upstate Medical University, Syracuse, NY 13210, USA.
American Journal of Clinical Pathology
|August 25, 2004
Summary
Researchers discovered a novel HLA-A0101 allele, a previously unknown human leukocyte antigen variant, in a family study. This finding highlights the importance of advanced DNA typing for identifying new HLA alleles and null variants.
Area of Science:
- Immunogenetics
- Molecular Biology
- Human Genetics
Background:
- Human Leukocyte Antigen (HLA) typing is crucial for transplantation and disease association studies.
- Serologic typing can sometimes yield ambiguous results, such as 'blank' alleles, necessitating further investigation.
- Genetic variations within HLA loci contribute to diverse immune responses.
Purpose of the Study:
- To identify and characterize a novel Human Leukocyte Antigen (HLA)-A1 null variant discovered in a family with near-identical parental haplotypes.
- To investigate the genetic basis of a 'blank' allele observed during serologic typing.
- To underscore the importance of advanced molecular typing techniques in immunogenetics.
Main Methods:
- Family-based genetic analysis of 8 individuals with near-identical parental haplotypes.
- Serologic antigen typing to initially assess HLA alleles.
- High-resolution DNA molecular HLA typing for detailed allele identification.
- Sequence-based typing to pinpoint specific nucleotide and amino acid substitutions.
Main Results:
- Identification of a novel HLA-A0101 allele, previously undetected by serologic methods.
- Discovery of a point mutation (C to G at nucleotide 215) resulting in an arginine to proline amino acid change (R48P) at codon 48 in exon 2.
- Demonstration that 'blank' alleles in serologic typing do not necessarily indicate homozygosity.
Conclusions:
- The study identified a new HLA-A1 null variant, HLA-A0101, caused by a specific point mutation.
- Results emphasize that 'blank' serologic typing results require confirmation with high-resolution DNA typing.
- The findings necessitate the availability of advanced molecular typing to accurately detect novel HLA alleles and null variants in immunogenetics laboratories.